TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 5 | 5 | 11 | 37 | 20 | 55 | 22 |
| P | %wins | 100 | 100 | 50 | 100 | 100 | 100 | 92 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/09 09:25 | 11/9/09 | CBRX | Columbia Laboratories Inc | DE | Health | Drug | Pharmaceutical Preparations | Gyenes Lawrence A | NJ | O | Senior V | P | 43 | 0.8657 | 0 | 50 | New | 50 | D | -64 | -50 | -47 | -31 | -36 | -37 | -9 | -3 | 5 | 6 | -1 | 46 | 37 | 49 |
5/19/05 09:14 | 5/17/05 | SVNT | Savient Pharmaceuticals Inc | DE | Health | MdCm | Medicinal Chemicals & Botanic | Gyenes Lawrence A | NJ | O | SVP,CFO | P | 46 | 3.07 | 1 | 15 | 51 | 44 | D | -20 | 34 | 38 | 5 | 20 | 18 | 7 | 4 | 4 | 4 | 22 | 28 | 3 | 61 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |